Want to join the conversation?
$ABT 2Q15 PR: Received European approval for Absorb GT1; completed submissions for regulatory approval of Absorb in Japan & US; submitted for US regulatory approval of FreeStyle Libre Pro Flash Glucose Monitoring System for professional use; received US FDA clearance for its i-STAT handheld system.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.